SCHEMBL6018093

SCHEMBL6018093

COC(=O)c1ccc(CN(C(=O)OC(C)(C)C)C(C)c2ncc[nH]2)c2ccccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.34
KDM4E B2RXH2 4/20 0.34
FPR2 P25090 3/20 0.33
NTRK1 P04629 1/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MMP1 P03956 1/20 0.32
MMP3 P08254 1/20 0.32
MMP7 P09237 1/20 0.32
AAK1 Q2M2I8 2/20 0.32
NR4A2 P43354 1/20 0.32
CREBBP Q92793 1/20 0.32
ATR Q13535 1/20 0.31
ADRA2A P08913 2/20 0.31
ADRA2B P18089 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018276 0.91 ADRA2A (0.34) FPR2NTRK1ALDH1A1MAPTL3MBTL1
SCHEMBL1638648 0.79 KDM4E (0.46) KDM4EFPR2ALDH1A1MMP3
SCHEMBL6018805 0.76 MAP2K1 (0.40) MAP2K1KDM4EFPR2ALDH1A1MAPT
SCHEMBL3107925 0.75 MAPK8 (0.39) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL1636497 0.74 SSTR4 (0.35) FPR2ALDH1A1MAPTL3MBTL1AAK1
SCHEMBL19334046 0.73 FPR2 (0.37) FPR2MMP1MMP3MMP7AAK1
SCHEMBL18829355 0.73 AAK1 (0.37) FPR2ALDH1A1MAPTMMP1MMP3
SCHEMBL6645846 0.73 ALDH1A1 (0.40) MAP2K1KDM4EALDH1A1LMNAMAPT
SCHEMBL1205086 0.73 KDM4E (0.43) MAP2K1KDM4EALDH1A1LMNAMAPT
SCHEMBL1638305 0.72 AAK1 (0.33) FPR2ALDH1A1L3MBTL1AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098215-B2 Nitrogenous compounds and antiviral drugs containing the same KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-08-29 US disclosed
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same KUREHA CORPORATION (JP) 2004-05-13 US disclosed
EP-1273571-A1 NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME Kureha Chemical Industry Co., Ltd. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same NSUN2, ZC3HAV1L, PNP MAP2K1 3244/4885KDM4E 3110/4885FPR2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.